PMID- 34300172 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210729 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 10 IP - 14 DP - 2021 Jul 6 TI - HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis. LID - 10.3390/jcm10143006 [doi] LID - 3006 AB - Spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases characterized by common clinical features, such as inflammatory enthesitis, arthritis and/or back pain. SpA is strongly associated with human leukocyte antigen (HLA) class I allotype B27. Ankylosing spondylitis has historically been the SpA subgroup with one of the strongest, best-proven associations with HLA-B27. The remaining SpA subgroups, namely psoriatic arthritis (PsA), inflammatory bowel diseases-associated arthritis/spondylitis, reactive arthritis, and undifferentiated SpA (uSpA), have also been associated with HLA allotypes other than HLA-B27. In this retrospective study, we analyzed the association between the HLA class I and II haplotypes and the susceptibility to enthesitis and/or arthritis (E/A). Special attention was paid to E/A responding to disease-modifying antirheumatic drugs (DMARDs) not fulfilling ASAS classification criteria (ASAS(-)), as compared to ASAS(+) forms including PsA and uSpA. The whole E/A group showed significant independent associations with HLA-A28(68), B27, Cw3, Cw12, and DQ1; taken singly, PsA was associated with HLA-B27 and DQ1, uSpA with HLA-B16(38,39) and B27, and E/A ASAS(-) with HLA-A28(68), Cw8, and Cw12. This study identified novel risk HLA allotypes for different SpA subgroups in an Italian population. HLA typing could aid the diagnosis and treatment of E/A subgroups, including DMARDS-responsive forms not fulfilling ASAS classification criteria. FAU - Favoino, Elvira AU - Favoino E AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Urso, Livio AU - Urso L AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Serafino, Alessandra AU - Serafino A AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Misceo, Francesca AU - Misceo F AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Catacchio, Giacomo AU - Catacchio G AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Prete, Marcella AU - Prete M AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. FAU - Perosa, Federico AU - Perosa F AUID- ORCID: 0000-0002-4072-4244 AD - Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. LA - eng GR - C.O.2018/University of Bari Medical School/ PT - Journal Article DEP - 20210706 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC8305973 OTO - NOTNLM OT - ASAS classification criteria OT - clinical management OT - human leukocyte antigen OT - spondyloarthritis OT - undifferentiated enthesitis and/or arthritis COIS- The authors declare no conflict of interest. EDAT- 2021/07/25 06:00 MHDA- 2021/07/25 06:01 PMCR- 2021/07/06 CRDT- 2021/07/24 01:06 PHST- 2021/05/28 00:00 [received] PHST- 2021/06/30 00:00 [revised] PHST- 2021/07/03 00:00 [accepted] PHST- 2021/07/24 01:06 [entrez] PHST- 2021/07/25 06:00 [pubmed] PHST- 2021/07/25 06:01 [medline] PHST- 2021/07/06 00:00 [pmc-release] AID - jcm10143006 [pii] AID - jcm-10-03006 [pii] AID - 10.3390/jcm10143006 [doi] PST - epublish SO - J Clin Med. 2021 Jul 6;10(14):3006. doi: 10.3390/jcm10143006.